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Heterotrimeric G-protein G subunits and GoLoco motif
proteins are key members of a conserved set of regulatory pro-
teins that influence invertebrate asymmetric cell division and
vertebrate neuroepithelium and epithelial progenitor differen-
tiation. GoLocomotif proteins bind selectively to the inhibitory
subclass (Gi) of G subunits, and thus it is assumed that a
GiGoLocomotif protein complex plays a direct functional role
in microtubule dynamics underlying spindle orientation and
metaphase chromosomal segregation during cell division. To
address this hypothesis directly, we rationally identified a point
mutation to Gi subunits that renders a selective loss-of-func-
tion for GoLoco motif binding, namely an asparagine-to-isole-
ucine substitution in the D–E loop of the G helical domain.
This GoLoco-insensitivity (“GLi”) mutation prevented Gi1
association with all human GoLoco motif proteins and abro-
gated interaction between the Caenorhabditis elegans G sub-
unit GOA-1 and the GPR-1 GoLoco motif. In contrast, the GLi
mutation did not perturb any other biochemical or signaling
properties ofGi subunits, includingnucleotide binding, intrin-
sic and RGS protein-accelerated GTP hydrolysis, and interac-
tions with G dimers, adenylyl cyclase, and seven transmem-
brane-domain receptors. GoLoco insensitivity rendered Gi
subunits unable to recruit GoLoco motif proteins such as
GPSM2/LGN and GPSM3 to the plasma membrane, and abro-
gated the exaggerated mitotic spindle rocking normally seen
upon ectopic expression of wild type Gi subunits in kidney
epithelial cells. This GLi mutation should prove valuable in
establishing the physiological roles ofGiGoLocomotif protein
complexes in microtubule dynamics and spindle function dur-
ing cell division aswell as to delineate potential roles forGoLoco
motifs in receptor-mediated signal transduction.
Seven transmembrane-domain receptors (7TMRs)2 mediate
the actions of various extracellular sensory, hormonal, andmet-
abolic stimuli (1). Among the signaling components coupled to
the intracytosolic side of 7TMRs are the heterotrimeric G-pro-
teins: molecular switches composed of a guanine nucleotide-
binding G subunit and a G dimer that transduce 7TMR
activation into intracellular modulation of multiple different
effectors, including adenylyl cyclases, ion channels, cyclic
nucleotide phosphodiesterases, and phospholipase C isoforms
(2, 3). 7TMR-promoted activation of G causes G to
exchange the more abundant GTP for bound GDP, which in
turn causes GGTP and G to dissociate. GGTP and G
are then free to regulate effector systems that alter cell physiol-
ogy (4, 5). This classical 7TMR-initiated G-protein nucleotide
cycle is reset by intrinsic GTP hydrolysis activity possessed by
the G subunit.
An evolutionarily conserved role for G subunits of the ad-
enylyl cyclase inhibitory (Gi) subfamily has recently been
identified in the control of mitotic spindle orientation in cell
divisions that generate cellular diversity during organismal
development (6, 7). Studies of asymmetric cell division in Cae-
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norhabditis elegans embryos and Drosophila melanogaster
embryonic neuroblasts have identified initial steps of this proc-
ess as generation of cell polarity and segregation of various cell
fate determinants to different sides of the polarized cell (8); the
mitotic spindle is then positioned to facilitate appropriate dis-
tribution of determinants to daughter cells during chromo-
somal segregation and cytokinesis. An integral part of the cel-
lular machinery underlying accurate spindle positioning is the
involvement of heterotrimeric G-proteinG andG subunits
in a manner considered independent of 7TMR activation and
instead involving RIC-8 (a cytosolic guanine nucleotide
exchange factor), GoLoco motif3 proteins (such as GPSM2/
LGN, Pins, and GPR-1/2 that act as GDP dissociation inhibi-
tors), and GTPase-accelerating proteins (“GAPs”; i.e. RGS pro-
teins) (6–13). Vertebrate neuroepithelial progenitors use the
same cellular machinery to modulate mitotic spindle orienta-
tion controlling the balance between asymmetric cell divisions
that drive differentiation and planar divisions that favor main-
tenance and expansion of the neuroepithelial architecture (14–
16). Similarly, an analogous mechanism appears to operate in
the stratification and differentiation of mammalian skin (17).
An essential feature of the various emerging models of
G-protein nucleotide cycling in mitotic spindle positioning is
the requirement for aGiGoLocomotif complex. For example,
in our working model of C. elegans asymmetric cell division
controlled by theG subunits GOA-1 andGPA-16 (18, 19), it is
the GGDP/GPR-1/2 complex that activates the generation
of astral microtubule (MT) force on mitotic spindle poles,
whereas in a competingmodel (3, 12, 20), the GGDP/GoLoco
motif complex is required for the nucleotide exchange (“GEF”)
activity for RIC-8, thereby generatingGGTP as the presumed
active form of the G-protein (12, 21, 22). However, it has not
been formally established that the G/GoLoco motif interac-
tion is required per se for the function of G subunits and
GoLoco motif proteins in mitotic spindle positioning. For
example, both models of C. elegans asymmetric cell division
have been generated primarily by correlating various genetic
phenotype data, including loss of pulling forces upon RNA
interference-mediated knockdown of goa-1/gpa-16 or gpr-1/2
expression (9–11, 18, 19). These phenotypic results, although
suggestive of a critical function for a GGoLoco protein com-
plex, might alternatively reflect separate and distinct functions
of G subunits and the multidomain GPR-1/2 proteins in par-
allel pathways culminating in MT force generation, given that
both classes of proteins have other binding partners and estab-
lished functions. Furthermore, it remains unresolved as to
whether G is an independent signaling entity in this system
or merely a buffer of free GGDP levels (14, 23, 24).
To provide a tool to address these questions, we sought to
design a variant G subunit that will not interact with GoLoco
motifs and yet retain wild type interactions with guanine nucle-
otides, 7TMRs, G subunits, G effectors, and RGS proteins.
Here we describe and validate a single point mutation that ren-
ders Gi subunits unable to bind GoLoco motif proteins, yet
preserves all other aspects of G function. Furthermore, we use
thisGoLoco-insensitivity (“GLi”)mutation to demonstrate that
direct G/GoLoco motif interaction is required for the G-de-
pendent modulation of MT dynamics during mitotic spindle
positioning.
EXPERIMENTAL PROCEDURES
Materials—All peptides were synthesized using Fmoc (N-(9-
fluorenyl)methoxycarbonyl) group protection, high pressure
liquid chromatography-purified, and validated by mass spec-
trometry at the Tufts University Core Facility (Medford, MA).
Fluorescent guanine nucleotides were from Invitrogen. Anti-
KT3 antibody MMS-125P was from Covance (Berkeley, CA).
Unless elsewhere specified, all additional reagents were of the
highest quality obtainable from Sigma or Fisher.
Molecular Biology—The expression vectors pcDNA3.1 human
Gi1 (Missouri Science andTechnology cDNAResource Center),
pPROEXHTb human Gi1 (25), pcDNA3.1 human Gi1-KT3
(26), pCI rat Gi1(C352G) (27), pCI rat Gi2(C353G) (27), pCI rat
Gi3(C352G) (27), and pPROEXHTb GOA-1 (encoding aa
28–351) (9) were each subjected to site-directed mutagenesis to
create N149I or N150I variants. All mutagenesis was performed
using the QuikChange system (Stratagene, La Jolla, CA). The
mammalian expression vectors pCI bovineG1 and pCI bovine
G2 are described inRef. 28, and pCI ratmGluR2 is described in
Ref. 29. pK mammalian expression vectors and derivatives
thereof (including venus yellow fluorescent protein (YFP)
fusion (30) (pK-VENUS), monomeric red fluorescent protein
(mRFP) fusion (31) (pK-mRFP), and 3 HA tag fusion (pK-
HA3)), originated from the Macara laboratory (University of
Virginia, VA) and are derived from pRK5 (BD Biosciences).
pK-YFP-GPSM2 and pK-Gi1-YFP are described in Ref. 32.
Wild type and N149I pK-Gi1-YFP, pK-Gi1-mRFP, and
pK-Gi1-HA3 were made by PCR amplification of
pcDNA3.1(Gi1, wild type and N149I) and subcloning into the
XbaI sites of pK-VENUS, pK-mRFP, and pK-HA3 respectively.
To construct pK-GPSM1-YFP, mouse GPSM1 cDNA was
PCR-amplified and subcloned into the BamHI/EcoRI sites of
pK-VENUS. A pFLAG expression construct encoding the
adenosine A2A receptor fused to venus-enhanced YFP is
described in Ref. 33. C. elegans RGS-7 in pBluescript was pro-
vided by Pierre Gonczy (ISREC, Lausanne, Switzerland). DNA
encoding the predicted minimal RGS domain of RGS-7 (aa
667–808 of RGS-7A (12)) was cloned into pPROEXHTb using
heterostagger PCR (34). All DNA constructs were verified by
DNA sequencing.
Protein Purification—GST fusion proteins were purified to
homogeneity using standardmethods (34, 35). The GST-GoLoco
motif fusion proteins purified were rat GPSM1(GL1234, aa 361–
650 (36)), human GPSM2 (GL1234, aa 481–657 (37)), human
GPSM3/G18 (GL123, aa 61–160 (26)), human PCP-2/GPSM4
(GL12, full-length (38)), rat RGS12 (aa 1184–1228 (25)), rat
RGS14 (aa 496–531 (39)), Rap1GAP1a (aa 1–34 (40)), and
Rap1GAP1b (aa 25–65 (40)) (see also supplemental Fig. S1 for a
graphical representation). G subunits were purified to homo-
geneity using previously described methods, including the
removal of His6 tags by tobacco etch virus protease cleavage
(25, 34, 35). The specific activities of wild type and N149I Gi1
were determined using [35S]GTPS binding (mean  S.E. of3 The GoLoco motif is also referred to as the G-protein regulatory motif (79).
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mol of GTPS bound per mol of Gi1) as follows: wild type,
0.93  0.02; N149I 0.93  0.02. C. elegans RGS-7, also with its
His6 tag removed, was purified to homogeneity using methods
standard for other RGS domains (41).
Surface Plasmon Resonance—Surface plasmon resonance
analysis of GoLoco motif/G interactions was conducted as
described in Refs. 25, 38.
Fluorescence Anisotropy—Fluorescence anisotropic assays of
G binding to FITC-labeled GoLoco motif peptides was con-
ducted as described in Ref. 42 for Fig. 2 and Fig. 7 and as
described in Ref. 40 for Fig. 3. Aminormodificationwas the use
of a 5 nM final concentration of the FITC-RGS14, FITC-RGS12,
FITC-GPSM2(GL2), and FITC-KB-1753 peptides. FITC-
RGS12 is described in Ref. 42. FITC-GPSM2(GL2) is described
in Ref. 40. FITC-KB-1753 is described in Ref. 43. The FITC-
RGS14 peptide included amino acids 496–531 of rat RGS14
(FITC--alanine-S-DIEGLVELLNRVQSSGAHDQRGLLR-
KEDLVLPEFLQ-NH2). Anisotropy data are presented as
millipolarization units (mP) following data analysis as
described in Ref. 42.
Nucleotide Binding and Hydrolysis Assays—[35S]GTPS
binding and [-32P]GTP hydrolysis assays were conducted as
described in Ref. 9, 44. [35S]GTPS binding was used to meas-
ure GPR-1/2-mediated GDI activity on GOA-1 as described in
Refs. 40, 44. The GPR-1/2 peptide (aa 423–461) is described in
Refs. 9, 42. BODIPYFL-GTPS binding assays were used to
quantify GoLoco motif-promoted Gi1 GDI activity, as
described previously (38). RGS domain-mediated acceleration
of GTP hydrolysis by 200 nM GOA-1 was measured using 100
nM BODIPYFL-GTP as described (34).
Dissociation of Superior Cervical Ganglion and cDNA
Microinjection—Detailed methods of preparing rat superior
cervical ganglion (SCG) neurons and cDNA microinjection
were described previously (27). In brief, adult male Wistar rats
were anesthetized by CO2 inhalation and decapitated as
approved by the Institutional Animal Care andUseCommittee.
Superior cervical ganglia were digested within modified Earle’s
balanced salt solution containing 0.6 mg/ml collagenase, 0.3
mg/ml trypsin, and 0.05 mg/ml DNase I for 1 h in a shaking
water bath at 36 °C under an atmosphere of 5% CO2, 95% O2.
The dissociated cells were then washed and plated on poly-L-
lysine-coated tissue culture dishes containing minimum essen-
tial medium and 10% (v/v) fetal calf serum. After cDNA injec-
tion, the neurons were incubated overnight at 37 °C, and
electrophysiology experiments were performed the next day.
For some experiments, neurons were incubated overnight with
500 ng/ml Bordetella pertussis toxin (PTX, List Biological
Laboratories, Campbell, CA). Microinjection of cDNA was
performed with an Eppendorf FemtoJet microjector and
5171 micromanipulator (Eppendorf, Madison, WI) using
custom designed software. Constructs containing inserts cod-
ing for mGluR2, Gi1(N149I, C352G), Gi2(N150I, C353G),
Gi3(N149I, C352G), Gi3(C352G), G1, and G2 were stored
at 20 °C as 0.6–1 g/l stock solutions in TE buffer (10 mM
Tris, 1mM EDTA, pH 8) and injected at a final concentration of
0.1 g/l.
Electrophysiolgical Studies—Themethod of recording whole
cell Ca2 currents from rat SCGneurons with anAxopatch 200B
amplifier (Molecular Devices, Sunnyvale, CA) was described in
detail previously (27, 45). Patch electrodes were fire-polished to
final resistances of2megohms when filled with internal solu-
tion. Uncompensated series resistance was 5 megohms and
electronically compensated 80%. Voltage protocol genera-
tion and data acquisition were performed using the custom-
designed software S5. Current traces were filtered at 2 kHz and
digitized at 10 kHz. All recordings were performed at room
temperature (21–24 °C).
Electrophysiology Solutions and Chemicals—The external
solution consisted of the following (in mM): 140 methanesulfo-
nic acid, 145 tetraethylammonium hydroxide (TEA-OH), 10
HEPES, 10 glucose, 10 CaCl2, and 0.0003 tetrodotoxin, pH 7.4,
with TEA-OH. The internal solution contained the following
(inmM): 120N-methyl-D-glucamine, 20TEA-OH, 11 EGTA, 10
HEPES, 10 sucrose, 1 CaCl2, 4 MgATP, 0.3 Na2GTP, and 14
Tris creatine phosphate, pH 7.2, with methanesulfonic acid.
The osmolalities of the external and internal solutions were
adjusted with sucrose to 325 and 300 mosmol/kg, respectively.
All drug and control solutions were applied to neurons via a
custom-designed gravity-driven perfusion system as described
previously (45).
Cyclic AMP Accumulation Assay—HEK 293 cells stably
expressing the ratD2L dopamine receptor (46) were propagated
in Dulbecco’s modified Eagle’s medium supplemented with 5%
(v/v) bovine calf serum, 5% (v/v) FetalClone 1 serum (Thermo
Fisher, Waltham, MA), 1 unit/ml penicillin, 1 g/ml strepto-
mycin, 2.5 ng/ml amphotericin B, and 2 g/ml puromycin and
maintained in a humidified incubator at 37 °C and 6% CO2.
Cells were seeded into 24-well cluster plates and, upon reaching
80% confluence, were transiently transfected with 200 ng of
pcDNA3.1(), pCI rat Gi1(Q204L, C352G), or Gi1(N149I,
Q204L, C352G) together with 50 ng of pFLAG-YFP-A2A using
Lipofectamine 2000 reagent (Invitrogen, 1 l/well). At 24 h
post-transfection, cAMP accumulation assays were carried out
on ice in Earle’s balanced salt solution containing 15 mM Na-
HEPES, 2% bovine calf serum, and 0.02% ascorbic acid follow-
ing a 5-min preincubation in assay buffer. Cyclic AMP was
stimulated by activation of the adenosine A2A receptor with the
agonist 5-N-methylcarboxamidoadenosine (MECA, 1 M) at
37 °C for 15 min in the presence of the phosphodiesterase
inhibitor 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one
(Ro-20-1724, 100 M). The stimulation medium was decanted,
and the reaction was terminated by addition of ice-cold 3%
trichloroacetic acid. The plate was stored at 4 °C for at least 1 h
before cAMP quantification. Cyclic AMP was quantified using
a competitive binding assay (47).
GPSM3MembraneRecruitment Experiments—Similar to the
transmembrane domain-anchored G subunits described in
Ref. 48, a pcDNA3.1-based mammalian expression vector was
generated to encode CFP-TM-Goi subunits consisting of
(starting at the N terminus) a signal peptide, enhanced CFP
(49), the N-terminal 103 amino acids of the rat -opioid recep-
tor, the N-terminal 33 amino acids of human GoA, and amino
acids 34–354 of human Gi1. A pcDNA3.1-based mammalian
expression vector was generated to encode YFP-GPSM3 con-
sisting of the venus variant of enhanced YFP (30), a c-Myc
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epitope tag, a hexahistidine tag, and human GPSM3 fused in-
frame (derived from pcDNA3.1mycHis human GPSM3 (26)).
Human embryonic kidney 293 cells (ATCC; Manassas, VA)
were propagated in plastic flasks and seeded onto polylysine-
coated glass coverslips according to the supplier’s protocol.
Cells were transfected using polyethyleneimine and were used
for experiments 12–48 h later. Coverslips bearing transfected
cells were imaged using a Leica (Bannockburn, IL) SP2 scan-
ning confocal microscope and a 63, 1.4 NA objective; cells
were excited using 458 nm (for CFP) or 514 nm (for YFP) laser
lines. Images were acquired and analyzed by an experimenter
who was blinded to the transfection condition. A 5-m profile
drawn normal to, and centered on, the plasma membrane was
obtained for each cell.
MDCK Cell and Spindle Rocking Experiments—MDCK II
cells were cultured, transfected, and processed for imaging as
described (32). MDCK cells were transfected with either wild
type or N149I Gi1-YFP. Time-lapse images of Hoechst 33342-
stained chromosomalDNAcondensation and segregationwere
recorded as described (32). The angles of the long axis of the
metaphase chromosomal array in each frame were measured
using Metamorph software (Molecular Devices, Sunnyvale,
CA). The absolute angle changes of at least 100 sets of adjacent
frames were binned into 5°, 5–10°, and 10° groups.
Co-immunoprecipitation—COS-7 cell culture, transfection,
and immunoprecipitation was performed as described (32).
Statistics and Curve Fitting—Unless otherwise indicated,
data analysis and curve fitting were performed using PRISM
version 4.0 (GraphPad; San Diego). All data are representative
of three or more independent experiments.
Structural Analysis of the GoLoco Motif/G Interaction—
The crystallographic structure of Gi1GDP bound to the
GoLoco motif of RGS14 has been determined at 2.7 Å resolu-
tion (PDB code 1KJY (39)), and more recently at 2.2 Å resolu-
tion (PDB code 2OM2 (50)). The two structures share the same
overall global architecture; however, there are appreciable dif-
ferences between the two structural models (50). In this study,
we confined our analysis to the 2OM2 structure, as it has higher
overall resolution and better refinement statistics. Similarly,
subtle but discrete differences exist between the two asymmet-
ric units in both 2OM2 and 1KJY structures; for this reason, we
have generally confined our analysis to the A and B chains of
2OM2 as the refinement of this asymmetric unit appeared
superior. PyMol (DeLano Scientific; PaloAlto, CA)was used for
analysis of structures and the generation of images. Amino acid
interaction data were derived using SPACE(CMA) (51) and
plotted using MATLAB (The MathWorks, Natick, MA).
RESULTS AND DISCUSSION
Rational Design of a Loss-of-Function Point Mutation in Gi
to Prevent GoLoco Motif Interaction—A major feature of the
Gi1GDP/RGS14 GoLoco motif complex (39, 50) consists of
the GoLoco motif N terminus forming an -helix that binds in
the pocket formed by the 2 helix (“switch II”) and the 3 helix
of the Ras-like domain of Gi1 (Fig. 1A). The invariant gluta-
mine residue (Gln515) of the GoLoco motif (D/E)QR triad ter-
minates this helical portion of the GoLoco motif. The GoLoco
motif peptide continues to transit across the surface of Gi1 to
contact the all -helical domain of Gi1. The conserved
Asp514–Gln515–Arg516 triad is responsible for turning the
GoLoco motif peptide and positioning Arg516 into the nucleo-
tide binding pocket of Gi1 so that the Arg516 side chain is able
to make direct contact with the - and -phosphates of GDP,
thus stabilizing the boundnucleotide and conferringGDI activ-
ity (39). The C-terminal segment of the GoLoco motif makes a
sharp hydrogen-bonded turn (Lys521–Glu522–Asp523–Leu524)
as it enters the central grove between theA- andB-helices of
the G-protein helical domain where it makes an extensive net-
FIGURE 1. Structural analysis of the function of Gil residue asparagine
149 in mediating the interaction between Gi1GDP and the GoLoco
motif of RGS14. Ribbon diagram of the RGS14 GoLoco motif (blue) bound to
Gi1GDP (yellow). G residues are annotated in red; GoLoco motif residues
are annotated in blue, and bound GDP is colored magenta. A, overall view of
the complex highlighting the position of the D/E helix. Asn149 is high-
lighted in stick format (red). B, enlarged view of the G/GoLoco motif interac-
tion interface. The side chain oxygen of Gln515 forms a hydrogen bonding
network with the side chain and backbone amine of Asn149. C, enlarged view
of intramolecular interactions of Asn149. The side chain amine of Asn149 forms
a hydrogen bond with the side chain oxygen of Ser80. Asn149 also makes
several stabilizing contacts with Arg178, predominantly between the -car-
bon of Asn149 and the -carbon of Arg178.
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work of contacts. The RGS14 GoLoco motif culminates in a
short 310 helix at amino acids Glu528–Phe529–Leu530. Thus, the
main points of contact betweenG and theGoLocomotif are in
the switch II/3 helix pocket, switch I, the helical domain (A
and B helices), the phosphate binding “P-loop,” and in the
D/E loop of the helical domain. A comprehensive analysis of
these G/RGS14 GoLoco motif interactions is reported in a
contact map in supplemental Fig. S2.
Based on these structural data (39, 50), it is not intuitively
obvious how to create a loss-of-function point mutation(s) in a
Gi subunit to abrogate GoLoco motif binding yet retain wild
type nucleotide binding and hydrolysis, receptor coupling, and
effector activation. Many of the GoLoco motif contact sites on
G are also used by other regulatory proteins (2, 39); this is
especially true for the main sites of GoLoco motif contact, e.g.
switch-II/3 helix, which is essential forG, effector, andRGS
domain interactions (2). Initial structure/function studies on
the molecular determinants of the G/GoLoco interaction
indicated that the D/E loop of the Gi1 helical domain was
essential for binding (52). In testing various Gi1/Gs chimeric
proteins, amino acids 144–151 in the D–E loop were iden-
tified by Natochin et al. (52) as one determinant responsible for
the inability of Gs to interact with
GoLoco motifs. The three residues
that differ between Gi1 and Gs in
the D–E loop are Arg144 to Asn,
Asn149 to Ile, and Ser151 to Cys
(illustrated in Fig. 2A). Examination
of the Gi1GDP/RGS14 GoLoco
motif structure indicates that, of
these three residues, only Asn149 of
Gi1 makes contact with the
GoLoco motif (Fig. 1B and supple-
mental Fig. S1). Asn149 is a Gi/o
class-specific residue (Fig. 2A) and
therefore also a good candidate for a
GoLoco motif interaction loss-of-
function mutation. We hypothe-
sized that a single point mutation of
N149I would be sufficient to selec-
tively abrogate GoLoco motif bind-
ing to Gi1 and create a GoLoco-
insensitive (GLi) G subunit. We
tested this hypothesis using multi-
ple independent techniques.
Asn149 to IleMutation inGil Pre-
vents Interaction with GoLoco
Motifs in Vitro—Mutation of the
Gi1 amino acid Asn149 to isoleu-
cine dramatically attenuated GDP-
dependent binding of Gi1 to the
GoLocomotif of RGS14, as assessed
by SPR spectroscopy (Fig. 2B). We
verified this attenuated affinity with
an independent measurement of
binding that employed fluorescence
anisotropy; the N149I mutation
reduced the calculated binding
affinity of Gi1GDP for the RGS14 GoLoco motif by 300-fold
(Fig. 2C). The signature biochemical activity of GoLoco motifs
is GDI activity (7). We therefore also tested GDI activity of the
RGS14 GoLoco motif on wild type and N149I Gi1 (Fig. 2, D
and E). We were unable to observe significant GoLoco motif-
mediated GDI activity using Gi1(N149I), whereas wild type
Gi1 was a substrate for RGS14 GoLoco motif GDI activity in
the nanomolar range (Fig. 2, D and E), as observed previously
(25).
To test the universality of this GoLoco-insensitivity point
mutation, we analyzed the binding of N149I Gi1 to all human
GoLoco motifs using SPR. A graphical representation of all
known GoLoco motif proteins, as well as the purified protein
constructs used in these SPR analyses, is presented in supple-
mental Fig. S2.4 Wild type Gi1 (at 1 M) exhibited robust,
GDP-selective binding to all known GoLoco motifs (Fig. 3,
A–G); at a 10-fold higher concentration, N149I Gi1 did not
demonstrate any binding toGPSM2 (Fig. 3B) nor to PCP-2 (Fig.
4 The GoLoco motif of Rap1GAP2 was not tested in these experiments as it is
devoid of GDI activity and incapable of functional interactions with Gi1,
Gi2, Gi3, and GoA (40).
FIGURE 2. Asparagine 149 is an evolutionarily conserved Gi/o class-specific amino acid that is crucial for
GoLoco motif interaction. A, multiple sequence alignment of the D/E loops within the all -helical
domains of human (Hs) G subunits. Sequences are grouped into the four classical G subclasses (s, i/o, q, and
12/13). C. elegans (Ce) and D. melanogaster (Dm) G subunits known to interact with GoLoco motifs are also
included in the alignment. SwissProt or GenBankTM accession numbers are as follows: human Gs, P63092;
human Golf, P38405; human GT1, P11488; human GT2, P19087; human GT3, NP_001095856; human GZ,
P19086; C. elegans GOA-1, P51875; D. melanogaster Go, P16378; human Gi1, P63096; human Gi2, P04899;
human Gi3, P08754; C. elegans GPA-16, Q60XS3; D. melanogaster Gi, P20353; human Go, P59215; human
Gq, P50148; human G14, O95837; human G15, P30679; human G12, Q03113; human G13, Q14344.
B, surface plasmon resonance was used to measure interactions between antibody-immobilized RGS14
GoLoco motif GST fusion protein and either GDP-bound or GDPAlF4
 bound G subunits. Injections of either 1
M Gi1(wild type) or 10 M Gi1(N149I) were used. Binding curves were obtained by subtracting nonspecific
binding to GST alone surfaces. C, affinity of wild type and N149I Gi1 proteins for the RGS14 GoLoco motif was
measured using fluorescence anisotropy. 5 nM FITC-RGS14(GoLoco motif) peptide was mixed with increasing
amounts of Gi1 proteins in the presence of either GDP or GDPAlF4
, and equilibrium fluorescence anisotropy
was measured (expressed as millipolarization units (mP) as described in Ref. 42). Dissociation constants were
determined by nonlinear regression: wild type Gi1GDP (14  1 nM). Dissociation constants for wild type
Gi1GDPAlF4
, N149I Gi1GDP, and N149I Gi1GDPAlF4
 could not be accurately determined as calculated
values were 50% of S.E.M. D, GDI effect of RGS14 GoLoco motif binding on Gi1GDP was quantified using
fluorescence spectroscopy. The fluorescence of 1 M BODIPYFL-GTPS was measured alone (blue trace) or in
the presence of 200 nM Gi1(N149I) (red trace), 200 nM Gi1(N149I)  1 M RGS14 (black trace), or 200 nM
Gi1(N149)  5 M RGS14 (green trace). E, concentration dependence of RGS14 GoLoco motif GDI activity was
measured by quantifying the initial rates of BODIPYFL-GTPS binding to 200 nM wild type Gi1(blue) or
Gi1(N149I) (red) in the presence of increasing amounts of RGS14 GoLoco motif. IC50 values were determined
by nonlinear regression (95% confidence intervals in parentheses): wild type Gi1, 243 (190 –310) nM; N149I
Gi1, 490 (220 –1000) M. RU, resonance units.
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3D). Low but measurable levels of N149I Gi1 binding were
observed on immobilized surfaces of GPSM1 (Fig. 3A), GPSM3
(Fig. 3C), and the GoLoco motifs of RGS12 (Fig. 3E),
Rap1GAP1a (Fig. 3F), and Rap1GAP1b (Fig. 3G). We used flu-
orescence anisotropy to further quantify the binding of
GPSM2(GL2) and RGS12GL to Gi1(N149I). Calculated KD
values for Gi1(N149I) versus wild type suggest that the GLi
mutation reduces affinity forGoLocomotifs by at least 700- and
200-fold, respectively (Fig. 3, H and I).
In Vitro Biochemical Properties of GoLoco-insensitive G
Subunits—Mutations inG subunits can alter nucleotide bind-
ing, nucleotide hydrolysis, and interaction with regulatory pro-
teins (53). We therefore wanted to test whether the GLi muta-
tion may have also altered the nucleotide binding and/or
hydrolysis properties of G subunits. Using [35S]GTPS bind-
ing, we observed that wild type andN149I Gi1 have equivalent
nucleotide exchange rates (Fig. 4A). The nucleotide exchange
rate as assayed by [35S]GTPS binding is an indirectmeasure of
spontaneous GDP release, and thus an index of G affinity for
GDP (54). Similarly, we used single turnover [32P]GTP hydrol-
ysis assays to measure the catalytic rate of GTPase activity for
wild type and N149I Gi1 (Fig. 4B). We observed no significant
difference in the ability of wild type or N149I Gi1 to hydrolyze
GTP. Finally, we constructed the GLi mutation (N150I) in the
C. elegans Go-like G-protein
GOA-1, known to functionally
interact with GoLoco motifs to reg-
ulate asymmetric cell division in the
one-cell embryo (9). We measured
RGS-75-mediated acceleration of
GTP hydrolysis by GOA-1. We
observed that the N150I mutation
had no appreciable effect on the
ability of RGS-7 to stimulate the
GTPase activity ofGOA-1 in a dose-
dependent fashion (Fig. 4C). Addi-
tionally, we verified that GOA-
1(N150I) is indeed resistant to
GoLoco motif-mediated GDI activ-
ity (Fig. 4D), suggesting that the Asn
to Ile mutation can be transferred
across species, consistent with the
conserved evolutionary relation-
ships among metazoan G-proteins
and GoLoco motif proteins (6, 7).
Functional Properties of the Go-
Loco-insensitive G—Ca2 channel
modulation in sympathetic neurons
was used to examine the ability of
GoLoco-insensitive G mutants to
complex with endogenous G
subunits. N-type Ca2 channels
respond to both tonic and 7TMR-
mediated G-protein activation with
a characteristic voltage-dependent
modulation mediated by G sub-
units (55). Ca2 channel currents in
whole-cell voltage-clamped neu-
rons were evoked with a double-pulse voltage protocol consist-
ing of two 25-ms test pulses to10mV separated by a depolar-
izing conditioning pulse to 80 mV (56). In control neurons
under basal conditions (Fig. 5A, open circle), the amplitude dur-
ing the first test pulse (prepulse) is slightly smaller than that
evoked by the second test pulse (postpulse) resulting in a mean
facilitation ratio (postpulse/prepulse amplitude) greater than 1
(Fig. 5F, open bar). Basal (in the absence of agonist) facilitation
has been shown to arise from tonic modulation by G sub-
units (28, 57). Application of norepinephrine (NE, 10 M) acti-
vates endogenous 2-adrenergic receptors, resulting in a large
inhibition of prepulse amplitude (Fig. 5A, filled circle; Fig. 5E,
open bar) and changes in current kinetics (slowing) and facili-
tation ratio characteristic of G modulation (55). Heterolo-
gous expression of GLi G subunits (Fig. 5, B–D) abolished
both tonic and agonist-mediated modulation as indicated by
decreases in mean basal facilitation (Fig. 5F) and agonist-medi-
ated inhibition of the prepulse amplitude (Fig. 5E). The
decreases were comparable with those produced by heterolo-
5 There is considerable confusion with regard to cross-organism RGS protein
nomenclature. Our experiments used C. elegans RGS-7 (GenBankTM acces-
sion number AY569308), which is likely the nematode ortholog of mam-
malian RGS3, a PDZ- and C2-domain-containing RGS protein (3, 80).
FIGURE 3. N149I substitution is a loss-of-function G mutation for all mammalian GoLoco motifs. The
universality of the Gi1 N149I mutation was analyzed by surface plasmon resonance. GST fusion proteins of the
GoLoco motifs of GPSM1(GL1,2,3,4) (A); GPSM2(GL1,2,3,4) (B); GPSM3(GL1,2,3) (C); PCP-2(GL1,2) (D); RGS12 (E);
Rap1GAP1a (F); and Rap1GAP1b (G) were immobilized on SPR biosensor surfaces. 1 M wild type Gi1GDP
(blue), 1 M wild type Gi1GDPAlF4
 (red), 10 M N149I Gi1GDP (green), and 10 M N149I Gi1GDPAlF4

(black) were separately injected over biosensor surfaces. Binding curves were obtained by subtracting non-
specific binding to GST alone. H, affinity of wild type and N149I Gi1 proteins for GPSM2(GL2) was measured
using fluorescence anisotropy. 5 nM FITC-GPSM(GL2) peptide was mixed with increasing amounts of Gi1
proteins, and equilibrium fluorescence anisotropy was measured. Data are expressed as millipolarization units
as described in Ref. 42. Dissociation constants were determined by nonlinear regression as follows: wild type
Gi1GDP (150  20 nM) and N149I Gi1GDP (99 M). I, affinity of wild type and N149I Gi1 proteins for the
RGS12 GoLoco motif was measured using fluorescence anisotropy. 5 nM FITC-RGS12 peptide was mixed with
increasing amounts of Gi1 proteins and equilibrium fluorescence anisotropy was measured. Data are
expressed as millipolarization units as described in Ref. 42. Dissociation constants were determined by nonlin-
ear regression: wild type Gi1GDP (44  6 nM), N149I Gi1GDP (9.3  0.5 M). RU, resonance units.
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gous expression ofGi3(C352G) (i.e. lacking theGLimutation).
These results indicate that GLi Gi subunits are capable of
binding constitutive G subunits and buffering G
“released” from heterotrimers activated by receptor stimula-
tion (58).
The ability to bind G subunits does not establish whether
the GLi G subunits are capable of forming functional hetero-
trimeric complexes. Thus, to examine directly the ability of GLi
G subunits to form functional heterotrimers, a reconstitution
assay was employed that utilizes a PTX-resistant mutation
(C-terminal cysteine to glycine mutation or “CG”) to distin-
guish responses arising from endogenous (PTX-sensitive) ver-
sus heterologously expressed G-containing heterotrimers
(27). Expression of the 7TMRmetabotropic glutamate receptor
(mGluR2) in sympathetic neurons renders Ca2 channels sen-
sitive to application of glutamate (Fig. 6A). The expressed
mGluR2 receptors couple to endogenous Gi/o family heterotri-
mers as indicatedby thenear complete sensitivityof thevoltage-
dependent inhibition to PTX pretreatment (Fig. 6B). Co-ex-
pression of a PTX-insensitive Gi3 mutant along with G1 and
G2 reconstituted the response in PTX-treated neurons (Fig.
6C) (29). Similarly, theGoLoco- and
PTX-resistant mutant Gi3(N149I,
C352G) was capable of reconstitut-
ing the response to glutamate fol-
lowingPTX treatment (Fig. 6D). Fig.
6E depicts the prepulse Ca2 cur-
rent inhibition for individual neu-
rons as well as the median response.
The magnitude of inhibition varies
for the PTX-resistant mutants as
the stoichiometric balance of G
and G influences the response
(59). These results demonstrate that
the Gi3(N149I,C352G) double
mutant is competent to form a
G heterotrimer that couples to




Our demonstration thatGLiG can
functionally couple to G-protein-
coupled receptors and G effec-
tors does not preclude the possibil-
ity that the GLi mutation is in some
waydeleterious toG effector inter-
actions. To address this possibility,
wemeasured the interaction of Gi1
with the G effector mimetic pep-
tide KB-1753. KB-1753 interacts
selectively with activated Gi sub-
units (i.e. GTPS and GDP/AlF4
forms but not GDP-bound G) in
an effector-like conformation by
binding to switch-II of Gi (43). We
measured the binding of wild type
and GLi Gi1 to KB-1753 using flu-
orescence anisotropy. Binding of both proteins to FITC-KB-
1753 was selective for the activated (GDP/AlF4) conformation
of G (Fig. 7A) and similar in magnitude (KD values as follows:
wild type, 294  40 nM; GLi, 311  40 nM).
The ability of the GoLoco-insensitive Gi1 mutant to inhibit
the G effector adenylyl cyclase was assessed by measuring the
inhibition of agonist-stimulated cAMP accumulation in cells
co-expressing constitutively active Gi1(Q204L) subunits and
the A2A adenosine receptor. Co-transfection of Gi1(Q204L)
inhibitedMECA-stimulated cAMPaccumulation bymore than
50% when compared with cells co-transfected with the vector
control (Fig. 7B). Cells co-expressing Gi1(N149I,Q204L) also
reduced MECA-stimulated cAMP accumulation, indicating
that GLi Gi1 retains the canonical Gi inhibitory function on
adenylyl cyclase.
Effect of the GoLoco-insensitivity Mutation on GoLoco Motif-
dependent Properties of Gi Subunits—To examine the effect of
the GLi mutation on G regulation of GoLoco motif protein
biology, we undertookmultiple approaches. Gi subunits facil-
itate the membrane localization of GoLoco motif proteins in
various model systems, including Drosophila neuroblasts and
FIGURE 4. Biochemical properties of GoLoco-insensitive G subunits. A, spontaneous nucleotide exchange
rates (kex) of wild type (black) and N149I (gray) Gi1GDP were measured. A time course of specific binding of
100 nM G subunit to 1 M GTPS was determined using an [35S]GTPS filter-binding assay. Data were fit to
single exponential functions with rate constants as follows: wild type Gi1 0.013  0.002 min
1 and N149I Gi1
0.009  0.0004 min1. B, spontaneous GTP hydrolysis rates (kcat) of wild type (black) and N149I (gray) Gi1 were
measured using [-32P]GTP hydrolysis assays. A time course of 32Pi (inorganic phosphate) production was
determined using activated charcoal filtration. Data were fit to single exponential functions with rate constants
as follows: wild type Gi1 0.40  0.003 min
1 and N149I Gi1 0.30  0.003 min
1. C, GTPase-accelerating
protein (GAP) activity of C. elegans RGS7 on 200 nM wild type and N150I-mutated C. elegans GOA-1 was meas-
ured using 100 nM BODIPYFL-GTP and fluorescence spectroscopy. Data were fit to the four parameter logistic
equation to determine EC50 values of RGS-7 GAP activity (95% confidence intervals in parentheses) as follows:
wild type GOA-1, 830 (570 –1300) nM; N149I GOA-1, 670 (580 –790) nM. D, GDI effect of the C. elegans GPR-1/2
GoLoco motif on C. elegans GOA-1 was quantified using [35S]GTPS filter binding. Time courses were obtained
by preincubating 100 nM GOA-1 (wild type or N150I) with either buffer or 10 M GPR-1/2 GoLoco motif peptide
for 5 min. Samples were then added to 1 M GTPS, and specific [35S]GTPS binding was quantified by filtration
and scintillation counting. Data were fit to exponential association functions (95% confidence intervals in
parentheses) as follows: wild type GOA-1 alone, 0.202 (0.160 – 0.240) min1; wild type GOA-1  GoLoco pep-
tide, 0.068 (0.055– 0.081) min1; N150I GOA-1 alone, 0.178 (0.150 – 0.210) min1; N150I GOA-1  GoLoco
peptide, 0.194 (0.140 – 0.250) min1.
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mammalian cell lines (23, 32). UsingMDCK cells, wemeasured
the ability of exogenously expressed KT3 epitope-tagged wild
type and GLi Gi1 subunits to regulate the cellular distribution
of endogenous GPSM2 (Fig. 8). We consistently observed that
wild type Gi1 expression promoted the plasma membrane
recruitment of GPSM2, whereas GLi Gi1 had no effect on
GPSM2 cellular distribution. Analogous results were observed
using mRFP-tagged Gi1 and endogenous GPSM2 (supple-
mental Fig. S3).We also observed that exogenous expression of
GPSM2 frequently resulted in the accumulation of GPSM2 in
“vesicle-like” intracellular organelles. These structures were
eliminated by co-transfection with wild type Gi1, presumably
by G-mediated recruitment of GPSM2 to the plasma mem-
brane (supplemental Fig. S4). However, co-transfection of YFP-
GPSM2withGi1(N149I) did not alter themorphology of YFP-
GPSM2-containing vesicular structures (supplemental Fig. S4).
We also examined the effect of the GLi mutation on interac-
tions between Gi1 and the triple GoLoco motif protein
GPSM3 (26). We used a CFP-tagged and transmembrane
domain-immobilized chimeric GoA/i1 subunit6 (“CFP-TM-
Goi”) to demonstrate the ability of G subunits to specify the
membrane localization of GPSM3 (48). Expression of YFP-
6 The chimeric GoA/i1 subunit, comprising the N-terminal 33 amino acids of
GoA and the remainder of the polypeptide sequence from Gi1, was origi-
nally created to facilitate kinetic imaging and functional assays not described
in this manuscript (G. J. Digby and N. A. Lambert, unpublished data). Of the 33
GoA-derived amino acids present within this G chimera, 22 are identical to
those found in Gi1, and 8 more are conservative substitutions (i.e., only three
positions represent nonconservative differences in side chain character). This
33-amino acid N-terminal region composes the flexible first -helix of G that
does not participate in the GoLoco motif interaction (7).
FIGURE 5. GoLoco-insensitivity mutation does not alter the ability of Gi
to buffer free G subunits. A–D, superimposed Ca2 current traces evoked
with a double-pulse voltage protocol in the absence (open circle) or presence
of 10 M NE (filled circle) from control (A), Gi1(N149I, C352G) (B), Gi2(N150I,
C353G) (C), and Gi3(N149I, C352G) (D) expressing SCG neurons. Currents
were evoked every 10 s. The dashed lines indicate the zero current level.
E, summary graph of Ca2 current inhibition by 10 M NE from control
neurons and neurons expressing Gi1(N149I,C352G), Gi2(N150I,C353G), or
Gi3(N149I,C352G). Ca
2 current inhibition was measured 10 ms after initiation
of the test pulse (10 mV) in the absence or presence of 10 M NE. F, basal
facilitation from control neurons or neurons expressing Gi1(N149I,C352G),
Gi2(N150I,C353G), or Gi3(N149I,C352G). Basal facilitation was calculated as the
ratio of Ca2 current amplitude determined from the test pulse (10 mV) occur-
ring after and before the 80 mV conditioning pulse. E and F, bars represent
meanS.E.M. Numbers in parentheses indicate the number of neuron tested. The
mean for all experimental conditions (colored bars) was different (p  0.05) from
the control condition (open bar) as determined by one-way analysis of variance
followed by Neuman-Keuls multiple comparison test. Means among experimen-
tal groups were not different.
FIGURE 6. GoLoco-insensitive Gi3 reconstitutes a functional heterotri-
mer that couples glutamate receptor activation to Ca2 channel inhibi-
tion. A and B, superimposed Ca2 current traces evoked with the double-
pulse voltage protocol in the absence or presence of 100 M glutamate from
SCG neurons heterologously expressing the metabotropic glutamate recep-
tor mGluR2 without (A) or with PTX pretreatment (B). C and D, superimposed
Ca2 current traces evoked with the same double-pulse protocol in the absence
and presence of 100 M glutamate from SCG neurons heterologously expressing
mGluR2, Gi3(C352G), G12 (C) or mGluR2, Gi3(N149I,C352G), G12 (D) after
pretreatment with PTX. E, summary graph of Ca2 current inhibition by 100 M
glutamate from neurons expressing different combinations of constructs as
described above. Solid line represents the intragroup medians. The median inhi-
bition for the mutant G reconstitution conditions differed significantly (p 
0.05) from the PTX-treated condition (Kruskal-Wallis test). Numbers in parentheses
indicate the number of neuron tested.
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tagged GPSM3 in the absence of co-expressed G subunits is
characterized by a uniform distribution of the GoLoco motif
protein throughout the cell (Fig. 9, left panel). Expression of
GPSM3-YFP in the presence of membrane-tethered, wild
type CFP-TM-Goi causes a redistribution of GPSM3 to the
plasmamembrane (Fig. 9,middle panel). In contrast, expres-
sion of GPSM3-YFP in the presence of the N149I mutant
CFP-TM-Goi results in a predominantly cytoplasmic distri-
bution of GPSM3 (Fig. 9, right panel). As yet another alter-
native technique to monitor Gi/GoLoco motif interaction
in cells, we used co-immunoprecipitation from lysates of co-
transfected COS-7 cells; both GPSM1 and GPSM2 inter-
acted robustly with wild type but not GLi, Gi1 (Fig. 10). In
summary, these data are all consistent with the GLi mutation
being a loss-of-function with respect to GoLoco motif bind-
ing in cells.
Structural Basis of the GoLoco-insensitivity Mutation—Our
data illustrate that the GLi mutation abrogates the ability of
Gi subunits and GoLoco motif proteins to interact in vitro
and in cells. Despite such an extreme loss-of-function in this
one aspect of G biology, the GLi G subunits behave nor-
mally in all other biochemical and cellular assays we have
conducted. There is ample precedent for finding such muta-
tions within G subunits; the RGS-insensitivity mutation
(G183S within Gi1) was first isolated in Saccharomyces cer-
evisiae Gpa1 (60), shown to be transferable to mammalian
Gi, Go, and Gq subunits (60, 61), and validated as affect-
ing only the G/RGS domain interaction without affecting
nucleotide, receptor, G, or effector interactions (62). To
better understand the potent and highly selective nature of
the GLi mutation, we re-analyzed the previously described
Gi1GDP/RGS14 GoLoco motif structure (50). Structural
analysis of this GGoLoco peptide complex indicates that
the predominant role of Asn149 within Gi1 is to directly
contact Gln515 of the RGS14 GoLoco motif. The side chain
oxygen of Gln515 forms a hydrogen bonding network with
both the side chain terminal amine (distance of 3.1 Å) and
the backbone amine (distance of 2.9 Å) of Asn149 (Fig. 1B).
Asn149 appears to be an important node in a network of Gi1
FIGURE 7. GoLoco-insensitive Gil has normal interactions with the effec-
tor adenylyl cyclase and the effector-mimetic peptide KB-1753. A, affinity
of wild type and N149I Gi1 proteins for the G-effector mimetic peptide
KB-1753 (43) was measured using fluorescence anisotropy. 5 nM FITC-KB-
1753 peptide was mixed with increasing amounts of Gi1 proteins, and equi-
librium fluorescence anisotropy was measured. Data are presented as the
mean  S.E.M. of triplicate determinations. Dissociation constants were
determined by nonlinear regression: wild type Gi1GDP (24.1  4 M), wild
type Gi1GDPAlF4
 (294  40 nM), N149I Gi1GDP (13.0  2 M), N149I
Gi1GDPAlF4
 (311  40 nM). B, cells were transiently transfected with cDNA
encoding Gi1(Q204L,C352G), Gi1(N149I,Q204L,C352G), or pcDNA3.1() as
a vector control, with the adenosine A2A receptor. Cyclic AMP accumulation
was stimulated with 1 M MECA for 15 min at 37 °C. Data represent the
mean  S.E.M. of four independent experiments in duplicate. *, p  0.05; **,
p  0.01 compared with A2A-R  empty vector transfection under matched
stimulation (basal or MECA), one-way analysis of variance followed by Dun-
nett’s post hoc test.
FIGURE 8. Wild type Gil, but not GoLoco-insensitive Gil, causes mem-
brane localization of endogenous GPSM2. MDCK II cells were transfected
with KT3-epitope tagged Gi1(wild type) (top panel) or Gi1(N149I) (bottom
panel). Twenty four hours later, cells were fixed and stained with anti-GPSM2
antibodies, anti-KT3 antibodies, and DNA was stained with 4,6-diamidino-2-
phenylindole. Images were obtained using confocal microscopy.
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amino acid residues, including
Glu43, Asn76, Gln79, Ser80, Gln147,
Leu148, and Arg178 that act to sta-
bilize the position of Gln515 in the
GoLoco motif (Fig. 1C and supple-
mental Fig. S5). Gln515 of the
GoLoco motif is crucial in posi-
tioning Arg516 into direct contact
with GDP, and to accomplish this
positioning, Gln515 makes a num-
ber of stabilizing interactions with
G residues in the P-loop, A
helix, switch I, and the D/E loop
(supplemental Figs. S2 and S5).
This network of residues, in which
Asn149 is involved, is also impor-
tant in stabilizing the “seatbelt”
between Glu43 and Arg178 hypoth-
esized to restrain the bound nucle-
otide within its binding pocket
(supplemental Fig. S5) (63, 64).
Although the only amino acid res-
idue of the RGS14 GoLoco motif
that directly contacts GDP is
Arg516 (Fig. 1B), GoLoco motif
binding to Gi1 induces a tighter
fit of GDP into the nucleotide
binding pocket (39). The salt
bridge interaction between the
P-loop residue Glu43 and the
switch I residue Arg178 likely sta-
bilizes bound GDP (39, 63, 65)
and, in cooperation with Arg516,
accounts for the structural deter-
minants of GDI activity. We also
observed that the backbone amine
of Asn149 contacts the side chain
of Ala512 (distance of 3.8 Å); how-
ever, this interaction was not
observable in all crystallographic
models7 and so may be of uncer-
tain significance.
Through multiple experimental methods, we have demon-
strated that theN149Imutation inGi does not perturb in vitro
biochemical nor in cellulo signal transduction properties of Gi
subunits. Based on the structural analysis described above, sub-
stitution of the amide side chain of Asn with the aliphatic side
chain of Ile would disrupt the hydrogen bonding network
between the side chain nitrogen of Asn149 and the side chain
carbonyl of Gln515 of the GoLoco motif. This is most likely
responsible for the majority of the loss-of-function phenotype
of the GLi mutation, as it appears that orientation of this
highly conserved glutamine is critical to GoLoco motif func-
tion. The only two amino acid positions completely con-
7 The RGS14 GoLoco motif residue Ala512 was observed to interact with
Asn149 of Gi1 in both asymmetric units in the PDB 2OM2 structure and the
chain A/chain B asymmetric unit of the PDB 1KJY structure.
FIGURE 9. GPSM3-YFP translocates to the plasma membrane after overexpression of transmembrane
domain-tethered wild type, but not GoLoco-insensitive G subunits. Confocal images of HEK 293 cells
transiently expressing GPSM3-YFP and either vector control (pcDNA; left panels), CFP-TM-GoA/i1 (middle pan-
els), or CFP-TM-GoA/i1 N149I (right panels). CFP fluorescence micrograph is shown above the corresponding
YFP fluorescence micrograph for the same cells. GPSM3-YFP fluorescence is distributed throughout the
nucleus and cytoplasm in control cells and in cells expressing CFP-TM-GoA/i1 with the GoLoco-insensitivity
N149I mutation, whereas GPSM3-YFP fluorescence is enriched at the plasma membrane in cells expressing
CFP-TM-GoA/i1. Average profiles of fluorescence intensity derived from lines drawn normal to the plasma
membrane are plotted below the micrograph panels. Peaks of CFP intensity document comparable expression
of CFP-TM-GoA/i1 (n 	 10 cells) and CFP-TM-GoA/i1 N149I (n 	 10 cells). a.u., arbitrary units.
FIGURE 10. GoLoco-insensitive Gil does not interact with GoLoco motif
proteins in cells. COS-7 cells were transfected with cDNAs encoding indi-
cated combinations of YFP-GPSM1, YFP-GPSM2, wild type Gi1-HA, and
N149I Gi1-HA. Cells were lysed, and total YFP- and HA-tagged protein levels
were analyzed by immunoblot (IB) with anti-HA and anti-green fluorescent
protein antibodies (left panel). Anti-HA antibody was added to the cell lysates
to immunoprecipitate (IP) C-terminal HA-tagged wild type or N149I Gi1.
Bound proteins were separated by SDS-PAGE and immunoblotted with
anti-HA and anti-green fluorescent protein antibodies (right panel).
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served in all functional GoLoco motifs (supplemental Fig. S1)
(7) are the Gln and the Arg8 residues of the DQR triad. In light
of this, we examined the role of Asn149 in Gi class subunits. As
described above, it has been noted that Asn149 is involved in
stabilizing the seatbelt configuration between G residues
Glu43 andArg178 that is partially responsible for GoLocomotif-
and G-mediated GDI activity (39, 63). However, in our stud-
ies, interaction between N149I mutant Gi subunits and G
subunits appeared to be normal, and this is consistentwithG
subunits having GDI activity toward Gs despite the Ile substi-
tution at this position inGs (66). AlthoughAsn149 is conserved
in all Gi/o subunits, the closely related Gz subunit contains a
histidine at this position (Fig. 2A). Interestingly, Gz is unique
amongG subunits in that it reportedly interacts with the trun-
cated GoLoco motif of Rap1GAP1a in a GTP-selective manner
(67) unlike the canonical G/GoLoco motif interaction, which
is GDP-selective (7).
Gi/GoLoco Motif Interaction Is Crucial for the Modulation
of Microtubule Dynamics—In mammalian cells, overexpres-
sion of either GPSM2 or wild type Gi1 has previously been
shown to destabilize the processes of mitotic spindle orienta-
tion and metaphase chromosome segregation (32). In MDCK
cells, this is characterized by an
increase in the amplitude of spindle
oscillations during metaphase (32).
The presumedmechanism of action
of Gi or GPSM2 overexpression on
spindle oscillations is an increased
recruitment of force-generating
GiGoLocomotif complexes to the
plasma membrane (32). Independ-
ently, it has also been observed that
overexpression of Gi3 or GPSM2
alters spindle pole positioning in
mammalian cells (68). However,
these observations are only sugges-
tive of a critical function for a
GGoLoco protein complex, given
that these results might alterna-
tively reflect separate, distinct func-
tions of G and GoLoco proteins in parallel pathways.
To delineate the precise role of Gi/GoLoco motif interac-
tions in ectopically induced spindle oscillations, we used
MDCK cells transfected with either wild type or GLi Gi1-YFP
and measured simple spindle oscillations using time-lapse
video microscopy. We observed that MDCK cells transfected
with wild type Gi1 underwent vigorous mitotic spindle oscil-
lations during mitosis, as described previously (32) (Fig. 11 and
supplemental movies 1 and 2), whereas at comparable expres-
sion levels, Gi1(N149I)-transfected cells did not exhibit
enhanced spindle rocking relative to untransfected cells (Fig. 11
and supplementalmovies 3 and 4). To quantify these results, we
measured the change of the long angle of metaphase chromo-
somal arrays during mitosis using image analysis. The ampli-
tude of spindle oscillations induced by wild type Gi1 expres-
sion was substantially higher than that found upon GLi Gi1
expression (Table 1). To our knowledge, this result represents
the first unambiguous demonstration that direct protein/pro-
tein interaction between Gi subunits and GoLoco motifs is
responsible for the modulation of cortical MT dynamics con-
trolling mitotic spindle orientation.
The precise mechanism of GiGoLoco motif complex-me-
diated regulation of cortical MT dynamics and spindle posi-
tioning during cell division is not clear. The use of our newly
describedGLiGi mutant in variousmodel systems of symmet-
ric and asymmetric cell division should help to clarify some of
the molecular mechanisms of these processes. In particular,
there are several important questions that remain unresolved.
First, what is the nature of the Gi nucleotide binding/hydrol-
ysis cycle that occurs during cell division? What is the active
Gi species (GGDP,GGDP/GoLoco complex, or GGTP),
and what is the hierarchy of participating G regulatory pro-
teins such as G, RIC-8, RGS proteins, and GoLoco motif
proteins? A consensus within the field appears to be that
GiGDP/GoLoco motif complexes represent the “active” spe-
cies during MT dynamics in cell division (69). However, the
order in which the nucleotide binding and hydrolysis cycle of
Gi progresses has not been resolved. A recent paper has
described RIC-8 as being able to act as a GEF onGoLocomotif-
liganded Gi subunits, thereby implying that GoLoco motif-
8 The GDP-binding arginine residue is a lysine in Rap1GAP2b/c GoLoco motifs
(40). However, these GoLoco motifs have no functional activity (40).
FIGURE 11. Wild type, but not GoLoco-insensitive, Gil-YFP destabilizes metaphase chromosomes and
spindle orientation. Time-lapse images of Hoechst 33342-stained chromosomes during metaphase align-
ment and segregation were recorded as described (32); supplemental movies are available. Representative
consecutive fluorescence images taken from time-lapse sequences showing the motion of Hoechst-stained
chromosomes in MDCK II cells expressing Gi1(wild type)-YFP (upper panel) and Gi1(N149I)-YFP (lower panel).
The images were taken every 3 s as described (32). To show the movements of the metaphase chromosomal
arrays, the position of the long axis of the chromosomal array along the metaphase plate in each image was
marked by red (upper panel) or blue lines (lower panel), and positions of the axis in previous adjacent images are
marked with white lines.
TABLE 1
Ectopic expression of wild type, but not GoLoco-insensitive, Gil-YFP
destabilizes spindle orientation
Time-lapse images of Hoechst 33342-stained chromosomes during metaphase of
MDCK II cells expressing Gi1(wild type)-YFP or Gi1(N149I)-YFP were recorded
as described (32). Consecutive fluorescence images were taken every 3 s during
mitosis (see supplemental movies 1–4 for example). The angles of the long axis of
the chromosomal arrays in each frame (see Fig. 11 for examples) were measured
using Metamorph software. The absolute angle changes of at least 100 sets of adja-
cent frames were binned into three categories: 5°, between 5 and 10°, and 10°.
Data are the mean (S.E.M.) values obtained from three independent time-lapse
analyses for either wild type or N149I Gi1-YFP-expressing cells.
Angle change during
spindle rocking
Relative frequency of observation (%)
Wild type Gil-YFP N149I Gil-YFP
0–5° 45 (3) 94 (2)
5–10° 38 (4) 6 (2)
10° 17 (2) 0
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bound Gi may be the physiological substrate for RIC-8 (22).
However, this same paper also demonstrated that the GoLoco
motif is a noncompetitive inhibitor of RIC-8 GEF activity (22),
in concordance with earlier results observed within the nema-
tode system (9).
Second, what is the direct mechanism by which Gi subunits
modulateMTdynamics? This latter question is beginning to be
understood. It appears that Gi proteins act to relieve intramo-
lecular auto-inhibition of “Pins-like” GoLoco motif proteins
(e.g.GPSM1/AGS3 andGPSM2/LGN).GiGDPbinding to the
GoLocomotifs of these multidomain proteins is believed to act
as a conformational switch, allowing the subsequent binding of
members of the nuclear mitotic apparatus/mushroom body
defect (NuMA/MUD) family of proteins (21, 32, 70). The
nuclear mitotic apparatus/mushroom body defect (NuMA/
MUD) proteins areMT-binding and -regulating proteins; thus,
their association with GiGoLoco motif protein complexes at
the cell cortex most likely modulates the dynamics of plus-end
astral MTs (71–73).
Conclusion—Our data presented here describe a single point
mutation in Gi/o subunits that selectively abrogates the ability
of G and GoLoco motifs to interact in vitro and in a cellular
context. This Asn to Ile mutation in the D/E loop of the
helical domain of G prevents the conserved GoLoco motif
glutamine residue from properly orienting the GDP-binding
arginine of theGoLocomotif.Wehave demonstrated the utility
of this mutant in interrogating the role of G proteins in the
modulation of mitotic spindle orientation. We anticipate the
widespread use of this GoLoco-insensitivity mutation in both
cell culture and in in vivo settings to address the physiological
roles of GGoLoco motif complex formation in diverse cell
division processes, akin to how the RGS-insensitivity mutation
of G subunits has been used to identify the physiological roles
of endogenous RGS proteins in 7TMR signaling strength and
duration (62, 74). A particularly important ancillary use of the
GoLoco-insensitivity mutation will be to delineate a potential
role forGoLocomotif proteins in 7TMR-mediated signal trans-
duction. Gain-of-function studies suggest that GPSM1/AGS3
can modulate the cellular levels of G subunits and thus indi-
rectly affect 7TMR signal transduction (75); other studies have
suggested that 7TMR signaling in vivo may be modulated by
GPSM1 and GPSM2 function (76–78). Application of the GLi
mutant to such studies will surely provide biochemical and
structural insights into the biological function of this important
class of G regulatory proteins.
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